Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival

Pancreatology

Volumn 14, Issue 4, 2014, Pages 295-301

  Xu, Yong Feng ^a,b   Lu, Yu ^a,b   Cheng, He ^a,b   Shi, Si ^a,b   Xu, Jin ^a,b   Long, Jiang ^a,b   Liu, Liang ^a,b   Liu, Chen ^a,b   Yu, Xianjun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Overall survival; Pancreatectomy; Pancreatic ductal adenocarcinoma (PDAC); Peripheral lymphocyte subsets; Prognosis; Tumor immunology

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; RADICAL RESECTION; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; SURVIVAL TIME; CARCINOMA, PANCREATIC DUCTAL; IMMUNOLOGY; LYMPHOCYTE COUNT; MIDDLE AGED; PANCREATIC NEOPLASMS; PATHOLOGY; PROGNOSIS; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS;

EID: 84905107127     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2014.05.797     Document Type: Article

References (51)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA A Cancer J Clin 60 2010 277 300
2. M. Hidalgo Pancreatic cancer N Engl J Med 362 2010 1605 1617
3. Y. Shaib, J. Davila, C. Naumann, and H. El-Serag The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. population-based study Am J Gastroenterol 102 2007 1377 1382 (Pubitemid 46976285)
4. A.C. Berger, M. Garcia Jr., J.P. Hoffman, W.F. Regine, R.A. Abrams, and H. Safran et al. Postresection ca 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by rtog 9704 J Clin Oncol Off J Am Soc Clin Oncol 26 2008 5918 5922
5. H.S. Wasan, G.M. Springett, C. Chodkiewicz, R. Wong, J. Maurel, and C. Barone et al. Ca 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone Br J Cancer 101 2009 1162 1167
6. N.A. Schultz, A. Roslind, I.J. Christensen, T. Horn, E. Hogdall, and L.N. Pedersen et al. Frequencies and prognostic role of kras and braf mutations in patients with localized pancreatic and ampullary adenocarcinomas Pancreas 41 2012 759 766
7. A.M. Krasinskas, A.J. Moser, B. Saka, N.V. Adsay, and S.I. Chiosea Kras mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas Mod Pathol Off J US Can Acad Pathol Inc 26 2013 1346 1354
8. J. Kim, H.A. Reber, S.M. Dry, D. Elashoff, S.L. Chen, and N. Umetani et al. Unfavourable prognosis associated with k-ras gene mutation in pancreatic cancer surgical margins Gut 55 2006 1598 1605 (Pubitemid 44629210)
9. N. Ishimura, K. Yamasawa, M.A. Karim Rumi, Y. Kadowaki, S. Ishihara, and Y. Amano et al. Braf and k-ras gene mutations in human pancreatic cancers Cancer Lett 199 2003 169 173 (Pubitemid 37297709)
10. J.R. Infante, H. Matsubayashi, N. Sato, J. Tonascia, A.P. Klein, and T.A. Riall et al. Peritumoral fibroblast sparc expression and patient outcome with resectable pancreatic adenocarcinoma J Clin Oncol Off J Am Soc Clin Oncol 25 2007 319 325 (Pubitemid 350003021)
11. K. Miyoshi, N. Sato, K. Ohuchida, K. Mizumoto, and M. Tanaka Sparc mrna expression as a prognostic marker for pancreatic adenocarcinoma patients Anticancer Res 30 2010 867 871
12. C.W. Steele, N.B. Jamieson, T.R. Evans, C.J. McKay, O.J. Sansom, and J.P. Morton et al. Exploiting inflammation for therapeutic gain in pancreatic cancer Br J Cancer 108 2013 997 1003
13. R. Kim, M. Emi, K. Tanabe, and K. Arihiro Tumor-driven evolution of immunosuppressive networks during malignant progression Cancer Res 66 2006 5527 5536 (Pubitemid 43927099)
14. M.T. Chow, A. Moller, and M.J. Smyth Inflammation and immune surveillance in cancer Semin Cancer Biol 22 2012 23 32
15. C.E. Clark, S.R. Hingorani, R. Mick, C. Combs, D.A. Tuveson, and R.H. Vonderheide Dynamics of the immune reaction to pancreatic cancer from inception to invasion Cancer Res 67 2007 9518 9527 (Pubitemid 47535942)
16. P. Fogar, D. Basso, E. Fadi, E. Greco, G. Pantano, and A. Padoan et al. Pancreatic cancer alters human cd4+ t lymphocyte function: a piece in the immune evasion puzzle Pancreas 40 2011 1131 1137
17. E. Tassi, F. Gavazzi, L. Albarello, V. Senyukov, R. Longhi, and P. Dellabona et al. Carcinoembryonic antigen-specific but not antiviral cd4+ t cell immunity is impaired in pancreatic carcinoma patients J Immunol 181 2008 6595 6603
18. N. Hiraoka, R. Yamazaki-Itoh, Y. Ino, Y. Mizuguchi, T. Yamada, and S. Hirohashi et al. Cxcl17 and icam2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis Gastroenterology 140 2011 310 321
19. N. Hiraoka, K. Onozato, T. Kosuge, and S. Hirohashi Prevalence of foxp3+ regulatory t cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clin Cancer Research Off J Am Assoc Cancer Res 12 2006 5423 5434 (Pubitemid 44497257)
20. D. Nummer, E. Suri-Payer, H. Schmitz-Winnenthal, A. Bonertz, L. Galindo, and D. Antolovich et al. Role of tumor endothelium in cd4+ cd25+ regulatory t cell infiltration of human pancreatic carcinoma J Natl Cancer Inst 99 2007 1188 1199 (Pubitemid 47233069)
21. U.L. Katari, J.M. Keirnan, A.C. Worth, S.E. Hodges, A.M. Leen, and W.E. Fisher et al. Engineered t cells for pancreatic cancer treatment HPB Off J Int Hepato Pancreato Biliary Assoc 13 2011 643 650
22. P. Cappello, B. Tomaino, R. Chiarle, P. Ceruti, A. Novarino, and C. Castagnoli et al. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen Int J Cancer J Int Du Cancer 125 2009 639 648
23. F. El Hage, A. Durgeau, and F. Mami-Chouaib Tap expression level in tumor cells defines the nature and processing of mhc class i peptides for recognition by tumor-specific cytotoxic t lymphocytes Ann N Y Acad Sci 1283 2013 75 80
24. D. Laheru, and E.M. Jaffee Immunotherapy for pancreatic cancer - science driving clinical progress Nat Rev Cancer 5 2005 459 467 (Pubitemid 40791488)
25. I. Mellman, G. Coukos, and G. Dranoff Cancer immunotherapy comes of age Nature 480 2011 480 489
26. B. Poch, E. Lotspeich, M. Ramadani, S. Gansauge, H.G. Beger, and F. Gansauge Systemic immune dysfunction in pancreatic cancer patients Langenbeck's Arch Surg/Dtsch Ges Chir 392 2007 353 358 (Pubitemid 46675798)
27. R. Pezzilli, D. Fabbri, A. Imbrogno, A.M. Morselli-Labate, and R. Corinaldesi Circulating lymphocyte subsets in pancreatic adenocarcinoma and their relationship to the stage of the disease Pancreas 41 2012 976 978
28. T. Yamamoto, H. Yanagimoto, S. Satoi, H. Toyokawa, S. Hirooka, and S. Yamaki et al. Circulating cd4+cd25+ regulatory t cells in patients with pancreatic cancer Pancreas 41 2012 409 415
29. L. Liu, H.X. Xu, W.Q. Wang, C.T. Wu, T. Chen, and Y. Qin et al. Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer Oncogene 33 2014 2728 2736
30. Y.F. Xu, Y. Yi, S.J. Qiu, Q. Gao, Y.W. Li, and C.X. Dai et al. Pebp1 downregulation is associated to poor prognosis in hcc related to hepatitis b infection J Hepatol 53 2010 872 879
31. M.Y. Cai, Y.F. Xu, S.J. Qiu, M.J. Ju, Q. Gao, and Y.W. Li et al. Human leukocyte antigen-g protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection Clin Cancer Research Off J Am Assoc Cancer Res 15 2009 4686 4693
32. A. McCabe, M. Dolled-Filhart, R.L. Camp, and D.L. Rimm Automated quantitative analysis (aqua) of in situ protein expression, antibody concentration, and prognosis J Natl Cancer Inst 97 2005 1808 1815 (Pubitemid 43033901)
33. C.E. Clark, G.L. Beatty, and R.H. Vonderheide Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer Cancer Lett 279 2009 1 7
34. F. Zhao, S. Obermann, R. von Wasielewski, L. Haile, M.P. Manns, and F. Korangy et al. Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma Immunology 128 2009 141 149
35. A.B. Borowski, A.C. Boesteanu, Y.M. Mueller, C. Carafides, D.J. Topham, and J.D. Altman et al. Memory cd8+ t cells require cd28 costimulation J Immunol 179 2007 6494 6503
36. W.L. Redmond, and L.A. Sherman Peripheral tolerance of cd8 t lymphocytes Immunity 22 2005 275 284 (Pubitemid 40387470)
37. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory t cells and immune tolerance Cell 133 2008 775 787 (Pubitemid 351707693)
38. W.H. Fridman, F. Pages, C. Sautes-Fridman, and J. Galon The immune contexture in human tumours: impact on clinical outcome Nat Rev Cancer 12 2012 298 306
39. A.M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein Increase of regulatory t cells in the peripheral blood of cancer patients Clin Cancer Research Off J Am Assoc Cancer Res 9 2003 606 612 (Pubitemid 36182591)
40. L.A. Ormandy, T. Hillemann, H. Wedemeyer, M.P. Manns, T.F. Greten, and F. Korangy Increased populations of regulatory t cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 2005 2457 2464 (Pubitemid 40490158)
41. F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii Increased populations of regulatory t cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clin Cancer Research Off J Am Assoc Cancer Res 9 2003 4404 4408 (Pubitemid 37248397)
42. I. Waldhauer, and A. Steinle Nk cells and cancer immunosurveillance Oncogene 27 2008 5932 5943
43. F. Mozaffari, C. Lindemalm, A. Choudhury, H. Granstam-Bjorneklett, I. Helander, and M. Lekander et al. Nk-cell and t-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy Br J Cancer 97 2007 105 111 (Pubitemid 47012095)
44. T. Nozoe, D. Korenaga, T. Ohga, M. Futatsugi, and Y. Maehara Suppression of the phytohemagglutinin response to lymphocytes is an independent prognosticator in patients with squamous cell carcinoma of the esophagus Ann Thorac Surg 76 2003 260 265 (Pubitemid 36819753)
45. T. Bauernhofer, I. Kuss, B. Henderson, A.S. Baum, and T.L. Whiteside Preferential apoptosis of cd56dim natural killer cell subset in patients with cancer Eur J Immunol 33 2003 119 124 (Pubitemid 36157649)
46. S. Platonova, J. Cherfils-Vicini, D. Damotte, L. Crozet, V. Vieillard, and P. Validire et al. Profound coordinated alterations of intratumoral nk cell phenotype and function in lung carcinoma Cancer Res 71 2011 5412 5422
47. E.A. Danna, P. Sinha, M. Gilbert, V.K. Clements, B.A. Pulaski, and S. Ostrand-Rosenberg Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease Cancer Res 64 2004 2205 2211 (Pubitemid 38339474)
48. S. Salvadori, G. Martinelli, and K. Zier Resection of solid tumors reverses t cell defects and restores protective immunity J Immunol 164 2000 2214 2220 (Pubitemid 30108782)
49. M. Nosotti, L. Rosso, P. Mendogni, A. Palleschi, D. Tosi, and P. Bonara et al. Leukocyte subsets dynamics following open pulmonary lobectomy for lung cancer: a prospective, observational study Interact Cardiovasc Thorac Surg 13 2011 262 266
50. L.F. Dodson, W.G. Hawkins, and P. Goedegebuure Potential targets for pancreatic cancer immunotherapeutics Immunotherapy 3 2011 517 537
51. S. Koido, S. Homma, A. Takahara, Y. Namiki, S. Tsukinaga, and J. Mitobe et al. Current immunotherapeutic approaches in pancreatic cancer Clin Dev Immunol 2011 2011 267539